• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Irritable Bowel Syndrome Epidemiology and Patient Flow Analysis - 2012 Product Image

Global Irritable Bowel Syndrome Epidemiology and Patient Flow Analysis - 2012

  • ID: 2293626
  • October 2012
  • Region: Global
  • 24 pages
  • Fore Pharma

Fore Pharma announced the results of its Irritable Bowel Syndrome patient population study in a new report ‘Global Irritable Bowel Syndrome Epidemiology and Patient Flow Analysis - 2012’. The report provides insights into Irritable Bowel Syndrome epidemiology, Irritable Bowel Syndrome diagnosed patients, and Irritable Bowel Syndrome treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Irritable Bowel Syndrome derived from epidemiological analysis, percentage of patients diagnosed with Irritable Bowel Syndrome, and percentage of patients treated with Irritable Bowel Syndrome therapy.

The study helps executives estimate Irritable Bowel Syndrome market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Irritable Bowel Syndrome prevalence, Irritable Bowel Syndrome diagnosis rate, and Irritable Bowel Syndrome treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:
- Irritable Bowel Syndrome: Disease Definition
- Irritable Bowel Syndrome Patient Flow
- Irritable Bowel Syndrome Prevalence
- Irritable Bowel Syndrome Diagnosed Patients
- Irritable Bowel Syndrome Treated Patients

1. Irritable Bowel Syndrome: Disease Definition
2. Global Irritable Bowel Syndrome Patient Flow
2A. Global Irritable Bowel Syndrome Prevalence
2B. Global Irritable Bowel Syndrome Diagnosed Patients
2C. Global Irritable Bowel Syndrome Treated Patients
3. Irritable Bowel Syndrome Patient Flow in the US
3A. Irritable Bowel Syndrome Prevalence in the US
3B. Irritable Bowel Syndrome Diagnosed Patients in the US
3C. Irritable Bowel Syndrome Treated Patients in the US
4. Irritable Bowel Syndrome Patient Flow in Europe
4A. Irritable Bowel Syndrome Prevalence in Europe
4B. Irritable Bowel Syndrome Diagnosed Patients in Europe
4C. Irritable Bowel Syndrome Treated Patients in Europe
5. Irritable Bowel Syndrome Patient Flow in Germany
5A. Irritable Bowel Syndrome Prevalence in Germany
5B. Irritable Bowel Syndrome Diagnosed Patients in Germany
5C. Irritable Bowel Syndrome Treated Patients in Germany
6. Irritable Bowel Syndrome Patient Flow in France
6A. Irritable Bowel Syndrome Prevalence in France
6B. Irritable Bowel Syndrome Diagnosed Patients in France
6C. Irritable Bowel Syndrome Treated Patients in France
7. Irritable Bowel Syndrome Patient Flow in Spain
7A. Irritable Bowel Syndrome Prevalence in Spain
7B. Irritable Bowel Syndrome Diagnosed Patients in Spain
7C. Irritable Bowel Syndrome Treated Patients in Spain
8. Irritable Bowel Syndrome Patient Flow in Italy
8A. Irritable Bowel Syndrome Prevalence in Italy
8B. Irritable Bowel Syndrome Diagnosed Patients in Italy
8C. Irritable Bowel Syndrome Treated Patients in Italy
9. Irritable Bowel Syndrome Patient Flow in UK
9A. Irritable Bowel Syndrome Prevalence in UK
9B. Irritable Bowel Syndrome Diagnosed Patients in UK
9C. Irritable Bowel Syndrome Treated Patients in UK
10. Irritable Bowel Syndrome Patient Flow in Japan
10A. Irritable Bowel Syndrome Prevalence in Japan
10B. Irritable Bowel Syndrome Diagnosed Patients in Japan
10C. Irritable Bowel Syndrome Treated Patients in Japan
11. Appendix
12. Research Methodology
12A. Sources

Table 1: Global Irritable Bowel Syndrome Patient Flow (2012)
Table 2: Global Irritable Bowel Syndrome Patient Flow Forecast (2012-2019)
Table 3: Irritable Bowel Syndrome Patient Flow in the US (2012)
Table 4: Irritable Bowel Syndrome Patient Flow Forecast in the US (2012-2019)
Table 5: Irritable Bowel Syndrome Patient Flow in Europe (2012)
Table 6: Irritable Bowel Syndrome Patient Flow Forecast in Europe (2012-2019)
Table 7: Irritable Bowel Syndrome Patient Flow in Germany (2012)
Table 8: Irritable Bowel Syndrome Patient Flow Forecast in Germany (2012-2019)
Table 9: Irritable Bowel Syndrome Patient Flow in France (2012)
Table 10: Irritable Bowel Syndrome Patient Flow Forecast in France (2012-2019)
Table 11: Irritable Bowel Syndrome Patient Flow in Spain (2012)
Table 12: Irritable Bowel Syndrome Patient Flow Forecast in Spain (2012-2019)
Table 13: Irritable Bowel Syndrome Patient Flow in Italy (2012)
Table 14: Irritable Bowel Syndrome Patient Flow Forecast in Italy (2012-2019)
Table 15: Irritable Bowel Syndrome Patient Flow in UK (2012)
Table 16: Irritable Bowel Syndrome Patient Flow Forecast in UK (2012-2019)
Table 17: Irritable Bowel Syndrome Patient Flow in Japan (2012)
Table 18: Irritable Bowel Syndrome Patient Flow Forecast in Japan (2012-2019)

Figure 1: Global Irritable Bowel Syndrome Patient Flow (2012)
Figure 2: Global Irritable Bowel Syndrome Patient Flow Forecast (2012-2019)
Figure 3: Irritable Bowel Syndrome Patient Flow in the US (2012)
Figure 4: Irritable Bowel Syndrome Patient Flow Forecast in the US (2012-2019)
Figure 5: Irritable Bowel Syndrome Patient Flow in Europe (2012)
Figure 6: Irritable Bowel Syndrome Patient Flow Forecast in Europe (2012-2019)
Figure 7: Irritable Bowel Syndrome Patient Flow in Germany (2012)
Figure 8: Irritable Bowel Syndrome Patient Flow Forecast in Germany (2012-2019)
Figure 9: Irritable Bowel Syndrome Patient Flow in France (2012)
Figure 10: Irritable Bowel Syndrome Patient Flow Forecast in France (2012-2019)
Figure 11: Irritable Bowel Syndrome Patient Flow in Spain (2012)
Figure 12: Irritable Bowel Syndrome Patient Flow Forecast in Spain (2012-2019)
Figure 13: Irritable Bowel Syndrome Patient Flow in Italy (2012)
Figure 14: Irritable Bowel Syndrome Patient Flow Forecast in Italy (2012-2019)
Figure 15: Irritable Bowel Syndrome Patient Flow in UK (2012)
Figure 16: Irritable Bowel Syndrome Patient Flow Forecast in UK (2012-2019)
Figure 17: Irritable Bowel Syndrome Patient Flow in Japan (2012)
Figure 18: Irritable Bowel Syndrome Patient Flow Forecast in Japan (2012-2019)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos